Sign In for increased benefits

Turn your one-off questions into a powerhouse research hub.

  • 🚨Real-time alerts on your custom watchlists
  • 🔍Unlock Deep Research Mode
  • 📊Exportable PDF/Word reports
  • 📚Revisit every question in your account history
  • ⭐Get personalised research and news based on your past questions
  • 🤝Team collaborate & annotate insights
  • 🌐Sync across devices—never lose your place
  • 👑Early-access to the next big AI features
  • 📚Continue enjoying 40 questions daily on your free account
About UsFAQsContact UsPrivacy PolicyCookies PolicyTerms and ConditionAcceptable Use PolicyData Processing Addendum
📢 New Earnings In! 🔍
Latest EarningsEarnings ChatEarnings FeedCompanies

Enanta Pharmaceuticals, Inc.

ENTA

Healthcare
Biotechnology
US

Company Overview

Detailed information about Enanta Pharmaceuticals, Inc.

Basic Information
Ticker: ENTA
Country: US
Headquarter: Watertown, MA
Employees: 131
Financial Information
Market Cap: $149.2 Million
Currency: USD
Sector: Healthcare
Industry: Biotechnology

Stock Data provided by Financial Modeling Prep

Company Description

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

Last Updated: Jul 2025

Here's what you can ask